Vanguard US Multifactor ETF Rating $170.65 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Vanguard US Multifactor ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.VFMF Aggregate RatingModerate Buy 2.66Holdings in VFMF have an aggregate rating of Moderate Buy based on 709 analyst ratings issued in the past year covering 27 companies (20.5% of the portfolio).VFMF Aggregate Price Target$170.65High Prediction$170.65Average Prediction$170.65Low Prediction$170.65Holdings in VFMF have an aggregate price target of $170.65 and a range of $170.65 to $170.65 covering 27 companies (20.5% of the portfolio).VFMF Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Vanguard US Multifactor ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 27 VFMF Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.98%NEMNewmont$107.74+0.1%4.956 of 5 stars2.88$142.05 31.8%24Positive News0.94%MOAltria Group$73.95+0.1%3.8375 of 5 stars2.27$69.33 -6.2%11Positive News0.92%ABBVAbbVie$216.02+0.1%4.9064 of 5 stars2.88$253.43 17.3%25Trending News0.91%BMYBristol Myers Squibb$59.51+0.1%4.7379 of 5 stars2.37$61.31 3.0%19Positive News0.89%MRKMerck & Co., Inc.$122.55+0.1%4.3796 of 5 stars2.68$128.18 4.6%19Trending News0.87%HCAHCA Healthcare$394.40+0.1%4.7854 of 5 stars2.63$515.77 30.8%240.84%MCKMcKesson$765.30-0.1%4.9312 of 5 stars2.82$968.87 26.6%170.83%XOMExxonMobil$154.82-0.1%4.319 of 5 stars2.57$163.95 5.9%21Trending News0.83%GILDGilead Sciences$134.364.6264 of 5 stars2.86$156.93 16.8%29Trending NewsAnalyst Revision0.83%MUMicron Technology$751.004.2619 of 5 stars3.03$518.47 -31.0%39Trending News0.80%LRCXLam Research$305.354.3153 of 5 stars2.79$293.46 -3.9%34Trending NewsDividend Announcement0.76%WFCWells Fargo & Company$76.52+0.2%4.9725 of 5 stars2.69$97.53 27.5%26Trending News0.75%AMGNAmgen$339.303.8997 of 5 stars2.48$355.19 4.7%31Trending NewsAnalyst Upgrade0.73%QCOMQualcomm$238.163.8047 of 5 stars2.29$181.79 -23.7%34Trending NewsOptions VolumeGap Down0.71%GOOGLAlphabet$382.974.3563 of 5 stars2.94$412.65 7.8%54Trending News0.71%JPMJPMorgan Chase & Co.$306.49+0.0%4.6561 of 5 stars2.50$339.08 10.6%30Trending NewsDividend Announcement0.69%JNJJohnson & Johnson$234.67+0.1%4.3272 of 5 stars2.74$253.04 7.8%27Trending News0.69%FDXFedEx$394.180.0%4.1533 of 5 stars2.59$399.62 1.4%29Trending NewsAnalyst Forecast0.68%CVSCVS Health$93.240.0%4.6189 of 5 stars2.85$98.68 5.8%26Trending News0.67%REGNRegeneron Pharmaceuticals$638.884.645 of 5 stars2.70$792.65 24.1%27Trending News0.67%PFEPfizer$25.92+0.1%3.9194 of 5 stars2.19$28.61 10.4%21Trending News0.65%CSCOCisco Systems$120.414.4621 of 5 stars2.77$118.14 -1.9%26Trending News0.64%WMTWalmart$120.274.647 of 5 stars2.97$138.71 15.3%36Trending NewsEarnings ReportAnalyst ForecastInsider Trade0.64%CORCencora$275.01+0.0%4.828 of 5 stars2.80$380.25 38.3%15Analyst DowngradeBuyback Announcement0.64%GSThe Goldman Sachs Group$996.730.0%4.1973 of 5 stars2.39$943.95 -5.3%23Trending News0.62%PEPPepsiCo$150.574.4159 of 5 stars2.37$170.11 13.0%19Trending News0.60%GMGeneral Motors$78.81+0.0%4.802 of 5 stars2.78$94.65 20.1%23Trending News This page (BATS:VFMF) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanguard US Multifactor ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanguard US Multifactor ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
